Gene · 6317
Papers2,569
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,569
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elucidating the NB-UVB mechanism by comparing transcriptome alteration on the edge and center of psoriatic plaques. | Sci Rep | 2023 | 36928592 | PubTator, text mining | PubMed |
| Plasma metabolomics study in screening and differential diagnosis of multiple primary lung cancer. | Int J Surg | 2023 | 36928390 | PubTator, text mining | PubMed |
| Isolation, characterization, proteome, miRNAome, and the embryotrophic effects of chicken egg yolk nanovesicles (vitellovesicles). | Sci Rep | 2023 | 36918605 | PubTator, text mining | PubMed |
| Tp53 haploinsufficiency is involved in hotspot mutations and cytoskeletal remodeling in gefitinib-induced drug-resistant EGFRL858R-lung cancer mice. | Cell Death Discov | 2023 | 36918558 | PubTator, text mining | PubMed |
| Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. | Int J Mol Sci | 2023 | 36901717 | PubTator, text mining | PubMed |
| Diagnostic Predictors of Immunotherapy Response in Head and Neck Squamous Cell Carcinoma. | Diagnostics (Basel) | 2023 | 36900006 | PubTator, text mining | PubMed |
| TNIP1 inhibits selective autophagy via bipartite interaction with LC3/GABARAP and TAX1BP1. | Mol Cell | 2023 | 36898370 | PubTator, text mining | PubMed |
| Primary diffuse Rosai-Dorfman disease in central airway: a case report and literature review. | BMC Pulm Med | 2023 | 36894897 | PubTator, text mining | PubMed |
| Interplay of adherens junctions and matrix proteolysis determines the invasive pattern and growth of squamous cell carcinoma. | Elife | 2023 | 36892272 | PubTator, text mining | PubMed |
| The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma. | Med Int (Lond) | 2023 | 36875818 | PubTator, text mining | PubMed |
A novel clinical diagnostic marker predicting the relationship between visceral adiposity and renal function evaluated by estimated glomerular filtration rate (eGFR) in the Chinese physical examination population. | Lipids Health Dis | 2023 | 36871015 | PubTator, text mining | PubMed |
| N6-methyladenosine of Spi2a attenuates inflammation and sepsis-associated myocardial dysfunction in mice. | Nat Commun | 2023 | 36864027 | PubTator, text mining | PubMed |
| Conceptualising the episodic nature of disability among adults living with Long COVID: a qualitative study. | BMJ Glob Health | 2023 | 36863719 | PubTator, text mining | PubMed |
| High-Throughput Peptide Arrays Identify Potential Diagnostic Autoantibody Signatures in Early-Stage Lung Adenocarcinoma. | Cancer Epidemiol Biomarkers Prev | 2023 | 36857775 | PubTator, text mining | PubMed |
| Peripheral Blood Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Systematic Review. | ACR Open Rheumatol | 2023 | 36852564 | PubTator, text mining | PubMed |
| Key Factors for "Fishing" NTCP as a Functional Receptor for HBV and HDV. | Viruses | 2023 | 36851726 | PubTator, text mining | PubMed |
| SWI/SNF Complex Genomic Alterations as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Multiple Cancers. | Cancer Immunol Res | 2023 | 36848524 | PubTator, text mining | PubMed |
| Pretreatment Carcinoembryonic Antigen Level Serves as a Potential Biomarker to Guide Adjuvant Radiotherapy in pT4N+ Colon Cancer Patients. | J Oncol | 2023 | 36844877 | PubTator, text mining | PubMed |
| A Clinical Decision Tool to Calculate Pretest Probability of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma. | Ann Surg Oncol | 2023 | 36840860 | PubTator, text mining | PubMed |
| SERPINB3, Adult-Onset Immunodeficiency, and Generalized Pustular Psoriasis. | Genes (Basel) | 2023 | 36833193 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6317/papers?page=16